Helius Medical Technologies, Inc.
HSDT
$6.21
-$0.06-0.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -140.89% | -47.25% | -32.68% | 30.19% | 12.15% |
| Total Depreciation and Amortization | 663.16% | -59.06% | -62.96% | -61.88% | -54.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 828.04% | 247.22% | 145.80% | -171.63% | 30.13% |
| Change in Net Operating Assets | 100.78% | 61.69% | 97.43% | -661.62% | -51.57% |
| Cash from Operations | -10.25% | -13.19% | -6.00% | -1.63% | 12.75% |
| Capital Expenditure | 100.00% | 100.00% | 82.76% | 66.67% | 44.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 82.76% | 66.67% | 44.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 122.32% | 101.61% | 173.64% | 669.04% | -76.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.47% | 2,744.20% | 5,990.77% | 10,655.56% | 621.17% |
| Cash from Financing | 36.11% | 256.22% | 545.68% | 1,565.05% | -52.58% |
| Foreign Exchange rate Adjustments | -- | -- | -300.00% | -50.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.03% | 67.16% | 56.29% | 69.01% | -141.53% |